GLP-1 Amîno Acid ji bo guhartina zincîra zincîreyê
Kîtekîteya Hilbera
| NA. | Wer | Cas No. | Bikaranînî | Nîşana kalîteya key | ||||
| Qiralîtî | Isomer | Si * | Max * | Şilî | ||||
| 1 | Fmoc-Lys (MTT) -OH | 167393-62-6 | Guhertina zincîra lysine | ≥99.0% | ≤0.1% | ≤ %,2% | ≤2.3% | ≤1.0% |
| 2 | Fmoc-lys (veqetandî) -oh | 146982-27-6 | Guhertina zincîra lysine | 999.5% | ≤0.1% | ≤0.1% | ≤ %,2% | ≤1.0% |
| 3 | Fmoc-lys (ivdde) -oh | 150629-67-7 | Guhertina zincîra lysine | ≥98.0% | ≤ %,2% | ≤2.3% | ≤0.5% | ≤1.0% |
| 4 | Fmoc-Lys (MMT) -OH | 159857-60-0 | Guhertina zincîra lysine | ≥98.0% | ≤ %,2% | ≤2.3% | ≤0.5% | ≤1.0% |
| 5 | Fmoc-glu-Otbu | 84793-07-7 | LiraglutideSemaglutide | 999.5% | ≤0.1% | ≤0.1% | ≤ %,2% | ≤1.0% |
| 6 | Glu-otbu | 45120-30-7 | LiraglutideSemaglutide | 999.5% | ≤0.1% | ≤0.1% | ≤ %,2% | ≤1.0% |
| 7 | Acid Octadecanedioic | 871-70-5 | Semaglutide | ≥99.0% | / | ≤ %,2% | ≤2.3% | ≤1.0% |
| 8 | Ocide Ocid Ocid Mono-Tert-Butyl Ester | 843666-40-0 | Semaglutide | ≥99.0% | / | ≤ %,2% | ≤2.3% | ≤1.0% |
| 9 | tbu-ooc-c16-co-glu-otbu | 1188328-39-3 | SemaglutideFragment a | ≥98.0% | ≤ %,2% | ≤0.5% | ≤0.5% | ≤1.0% |
| 10 | Aeea | 134978-97-5 | SemaglutideAlbuvirtDE | ≥99.0% | / | ≤ %,2% | ≤2.3% | ≤1.0% |
| 11 | Aeea-oh.hcl | 134979-01-4 | SemaglutideAlbuvirtDE | ≥99.0% | / | ≤ %,2% | ≤2.3% | ≤1.0% |
| 12 | Fmoc-Aeea-Oh | 166108-71-0 | SemaglutideAlbuvirtDE | ≥99.0% | / | ≤ %,2% | ≤2.3% | ≤1.0% |
| 13 | Boc-aeea-oh | 108466-89-3 | Semaglutide | ≥99.0% | / | ≤ %,2% | ≤2.3% | ≤1.0% |
| 14 | Aeea-aeea | 1143516-05-5 | Semaglutide | ≥98.0% | ≤ %,2% | ≤0.5% | ≤0.5% | ≤1.0% |
| 15 | Fmoc-Aeea-Aeea-OH | 560088-89-3 | SemaglutideFragment B | ≥98.0% | ≤ %,2% | ≤0.5% | ≤0.5% | ≤1.0% |
| 16 | Octa (otbu) -glu (ɑ-otbu) -Aeea-aeea-oh | 1118767-16-0 | SemaglutideFragment c | ≥98.0% | ≤ %,2% | ≤0.5% | ≤0.5% | ≤1.0% |
| 17 | tbu-ooc-c16-co-glu (aeea-aeea-nhs) -otbu | 1118767-15-9 | SemaglutideFragment D | ≥96.0% | ≤0.5% | ≤1.0% | ≤1.0% | ≤1.0% |
| 18 | Fmoc-lys (tbu-ooc-c16-co-glu (aeea-aeea) -otbu) -oh | 1662688-20-1 | Parçeyek semaglutide e | ≥96.0% | ≤0.5% | ≤1.0% | ≤1.0% | ≤1.0% |
| 19 | Boc-wî (TRT) -OH | 32926-43-5 | Dawîn histidine ye | 999.5% | ≤0.1% | ≤0.1% | ≤ %,2% | ≤4.0% |
| 20 | Fmoc-Aib-Oh | 94744-50-0 | Semaglutide | 999.5% | / | ≤0.1% | ≤ %,2% | ≤1.0% |
| 21 | Boc-wî (TRT) -Aib-Oh | 2061897-68-3 | Semaglutide | ≥99.0% | ≤0.1% | ≤ %,2% | ≤2.3% | ≤2.0% |
| 22 | FMOC-Glu (Otbu) -gly-oh | 866044-63-5 | GLP-1 analogue | 999.5% | ≤0.1% | ≤ %,2% | ≤ %,2% | ≤1.0% |
| 23 | Boc-wî (TRT) -aib-glu (Otbu) -gly-oh | 1169630-31-2? | Parçeyek semaglutide f | ≥98.0% | ≤ %,2% | ≤0.5% | ≤0.5% | ≤1.0% |
| 24 | Boc-wî (TRT) -aib-glu (Otbu) -gly-nhs | 1169630-40-3 | Paragment semaglutide g | ≥96.0% | ≤0.5% | ≤1.0% | ≤1.0% | ≤1.0% |
| 25 | Fmoc-arg (PBF) -gly-oh | 660846-80-0 | GLP-1 analogue | 999.5% | ≤0.1% | ≤ %,2% | ≤ %,2% | ≤1.0% |
| 26 | Fmoc-Ala-Ala-Oh | 87512-31-0 | GLP-1 analogue | 999.5% | ≤0.1% | ≤ %,2% | ≤ %,2% | ≤1.0% |
| 27 | FMOC-ThR (TBU) -PHE-OH | 1260609-75-3? | GLP-1 analogue | 999.5% | ≤0.1% | ≤ %,2% | ≤ %,2% | ≤1.0% |
| 28 | Acid palmitic | 1957/10/3 | Liraglutide Fragment 1 | ≥99.0% | / | ≤ %,2% | ≤2.3% | ≤1.0% |
| 29 | Palm-glu-otbu- | NA | Liraglutide Fragment 2 | ≥98.0% | ≤ %,2% | ≤0.5% | ≤0.5% | ≤1.0% |
| 30 | Palm-Glu (NES) -Otbu | NA | Liraglutide Fragment 3 | ≥96.0% | ≤0.5% | ≤1.0% | ≤1.0% | ≤1.0% |
| 31 | Fmoc-lys (palm-glu-otbu) -oh | 1491158-62-3 | Liraglutide | ≥98.0% | ≤ %,2% | ≤0.5% | ≤0.5% | ≤1.0% |
| 32 | Hexadecanedioic Acid | 505-54-4 | Insulin degludec | ≥99.0% | / | ≤ %,2% | ≤2.3% | ≤1.0% |
| 33 | Hexadecanedioic Acid Mono-Tert-Butyl Ester | 843666-27-3 | Insulin degludec | ≥99.0% | / | ≤ %,2% | ≤2.3% | ≤1.0% |
| 34 | tbu-ooc-c14-co-gl-otbu | NA | Insulin Degludec Fragment I | ≥98.0% | ≤ %,2% | ≤0.5% | ≤0.5% | ≤1.0% |
| 35 | tbu-ooc-c14-co-glu (nes) -otbu | NA | Insulin Degludec Fragment II | ≥96.0% | ≤0.5% | ≤1.0% | ≤1.0% | ≤1.0% |
SI * = Nexşeya taybetî
Max * = Max Nekêşbar
Nîşana din:
- acîdê acetîk: ≤0.02% (hemî hilber)
- Ethyl Acetate: ≤0.5% (hemî hilber)
- alkol: ≤0.5% (hemî hilber)
Sanahîbûn
Sanasyona pergala belavkirinê, tevî tankê loop û hilanînê ji hêla pasteurization ve tête kirin. Dema ku paqijkirinasyona pasteurization tête kirin, ava paqijkirî ya di tankê de heya 80 ° C tê germ kirin û dest bi belavkirina pergala belavkirinê dikin. Sanahî piştî gihîştina 80 ° C. Sanahî her çaryeka tê kirin. Logoya Sanî ya Sanahî ya Paqijkirî ya Sanîtîfaqî hate kontrolkirin bêyî rêwîtiya balkêş.
